RWE Steering Committee Meeting Summary - June 13, 2023
CADTH provided updates on its Scientific Advice program and Post-Market Drug Evaluation. CIOMS shared a report on using real-world data in decision-making. CDA-TO sought input on drug analytics. The committee discussed its mandate and membership for future meetings.
0 views • 5 slides
Overview of Pharmaceutical Pricing and Regulation in Canada
The pharmaceutical pricing and reimbursement system in Canada is unique due to the absence of a national pharmaceutical negotiator and formulary. The Patented Medicine Prices Review Board (PMPRB) sets price ceilings federally, while provincially, the CADTH reviews drugs for reimbursement recommendat
0 views • 23 slides